Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices.

Steven Gilmore,Melissa Carroll,Elizabeth Koselke,Shannon Hough

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners（2023）

引用 0|浏览0

暂无评分

摘要

Guideline revision and electronic health record modification resulted in a 27% reduction in the mean rasburicase dose and a 50% reduction in repeat rasburicase dosing without a negative impact on clinical efficacy.

查看译文

关键词

Rasburicase, tumor lysis syndrome, hyperuricemia, guideline, costsaving

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要